Osteoporosis Drug Approval Highlights AJPB Week in Review

Article

Top news of the week from The American Journal of Pharmacy Benefits.

5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment

The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Related Content
Image credit: Jo Panuwat D | stock.adobe.com

Phase 2 Trial Data Show That Novel Antibiotic Led to 96% Cure Rate for C diff Infection

December 1st 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 2

Pharmacy Focus: Conversations On Reproductive Health - Episode 2

November 29th 2023
Podcast
Siarhei - stock.adobe.com

Gene Associated With Autism Spectrum Disorder May Disrupt Early Brain Development

December 1st 2023
Article
Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

November 28th 2023
Podcast
Image credit: Tada Images | stock.adobe.com

FDA Offers Priority Review to Enfortumab Vedotin-Ejfv, Pembrolizumab Combination for Metastatic Bladder Cancer

December 1st 2023
Article
biosimilar word or concept represented by wooden letter tiles on a wooden table | Image Credit: lexiconimages - stock.adobe.com

Biosimilar Candidate GP40141 Found Similar to Romiplostim for Idiopathic Thrombocytopenic Purpura

December 1st 2023
Article
© 2023 MJH Life Sciences

All rights reserved.